Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - VARIAN MEDICAL SYSTEMS INC | exhibit322-2020q1.htm |
EX-31.2 - EX-31.2 - VARIAN MEDICAL SYSTEMS INC | exhibit312-2020q1.htm |
EX-31.1 - EX-31.1 - VARIAN MEDICAL SYSTEMS INC | exhibit311-2020q1.htm |
EX-10.1 - EX-10.1 - VARIAN MEDICAL SYSTEMS INC | ex101rsuagreement.htm |
10-Q - 10-Q - VARIAN MEDICAL SYSTEMS INC | var-20200103.htm |
Exhibit 32.1
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report of Varian Medical Systems, Inc. (the “Company”), on Form 10-Q for the quarter ended January 3, 2020 (the “Report”), I, Dow R. Wilson, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002 that:
(1)the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: | February 11, 2020 | /s/ | Dow R. Wilson | ||||||||
Dow R. Wilson | |||||||||||
President | |||||||||||
and Chief Executive Officer |